Litcius/Paper detail

Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) – an International mRCC Database Consortium (IMDC) analysis

Daniel Vilarim Araújo, J. Connor Wells, Aaron R. Hansen, Nazlı Dizman, Sumanta K. Pal, Benoit Beuselinck, Frede Donskov, Chun Loo Gan, Flora Yan, Ben Tran, Christian Kollmannsberger, Guillermo de Velasco, Takeshi Yuasa, M. Neil Reaume, D. Scott Ernst, Thomas Powles, Georg A. Bjarnason, Toni K. Choueiri, Daniel Y.C. Heng, Shaan Dudani

2021Journal of Geriatric Oncology24 citationsDOI

Topics & Concepts

MedicineRenal cell carcinomaOncologyInternal medicineIntensive care medicineRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) – an International mRCC Database Consortium (IMDC) analysis | Litcius